我武生物
(300357)
| 流通市值：122.91亿 | | | 总市值：132.99亿 |
| 流通股本：4.84亿 | | | 总股本：5.24亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 847,051,729.58 | 797,222,807.56 | 1,055,130,256.56 | 1,108,332,544.64 |
| 交易性金融资产 | 477,997,668.83 | 560,226,151.32 | 286,816,966.83 | 254,720,530.82 |
| 应收票据及应收账款 | 254,139,824.63 | 191,965,294.12 | 284,816,975.05 | 207,659,904.06 |
| 其中：应收票据 | 12,705,898.99 | 28,746,028.46 | 21,429,211.62 | 16,130,521.19 |
| 应收账款 | 241,433,925.64 | 163,219,265.66 | 263,387,763.43 | 191,529,382.87 |
| 应收款项融资 | 41,120,432.96 | 50,969,469.99 | 61,357,636.77 | 22,745,824.95 |
| 预付款项 | 2,576,124.43 | 1,987,401.52 | 3,363,437.9 | 3,825,822.57 |
| 其他应收款合计 | 6,923,156.47 | 6,093,122.99 | 6,203,299.27 | 7,145,466.44 |
| 存货 | 53,678,151.57 | 54,757,678.12 | 53,703,749.67 | 56,352,446.58 |
| 一年内到期的非流动资产 | 75,083,493.15 | 74,579,246.57 | - | - |
| 其他流动资产 | 5,851,001.91 | 23,444,933.33 | 20,933,123.89 | 22,779,488.4 |
| 流动资产合计 | 1,764,421,583.53 | 1,761,246,105.52 | 1,772,325,445.94 | 1,683,562,028.46 |
| 非流动资产: | | | | |
| 其他债权投资 | 31,592,863.01 | 31,404,602.74 | - | - |
| 长期股权投资 | 221,262,438.64 | 71,484,095.56 | 71,829,011.82 | 72,082,842.5 |
| 其他权益工具投资 | - | 5,428,577.14 | 5,428,577.14 | 5,428,577.14 |
| 固定资产 | 559,731,170.2 | 653,436,068.39 | 658,866,424.66 | 425,674,204.17 |
| 在建工程 | 177,597,774.93 | 175,455,228.03 | 178,736,422.16 | 393,949,073.84 |
| 使用权资产 | 14,753,658.95 | 13,955,025.69 | 15,377,578.61 | 16,800,131.52 |
| 无形资产 | 126,591,813.14 | 149,455,328.48 | 151,861,174.56 | 155,502,954.49 |
| 开发支出 | 22,610,781.77 | 19,750,592.08 | 22,769,213.07 | 21,597,087.37 |
| 长期待摊费用 | 6,925,633.19 | 6,559,426.11 | 5,648,096.66 | 5,730,681.01 |
| 递延所得税资产 | 6,197,631.79 | 5,576,330.86 | 6,776,303.02 | 6,053,438.94 |
| 其他非流动资产 | 4,577,209.4 | 3,642,901.08 | 3,595,629.6 | 3,696,023 |
| 非流动资产合计 | 1,171,840,975.02 | 1,136,148,176.16 | 1,120,888,431.3 | 1,106,515,013.98 |
| 资产总计 | 2,936,262,558.55 | 2,897,394,281.68 | 2,893,213,877.24 | 2,790,077,042.44 |
| 流动负债: | | | | |
| 短期借款 | 5,003,666.66 | 5,003,743.06 | 5,000,000 | 5,051,595.14 |
| 应付票据及应付账款 | 14,421,659.12 | 31,406,823.18 | 36,033,972.85 | 31,276,375.47 |
| 应付账款 | 14,421,659.12 | 31,406,823.18 | 36,033,972.85 | 31,276,375.47 |
| 合同负债 | 635,186.26 | 527,291.08 | 633,998.53 | 569,712.21 |
| 应付职工薪酬 | 20,267,146.23 | 28,648,203 | 26,994,145.66 | 20,587,159.06 |
| 应交税费 | 16,328,815.37 | 11,251,241.58 | 33,512,906.39 | 19,864,342.47 |
| 其他应付款合计 | 6,666,004.22 | 63,654,219.65 | 13,101,765.49 | 97,766,477.52 |
| 其中:应付利息 | - | - | 3,402.78 | - |
| 应付股利 | - | 52,358,400 | - | 62,830,080 |
| 一年内到期的非流动负债 | 4,184,516.54 | 4,082,452.11 | 4,676,070.39 | 5,080,614.08 |
| 流动负债合计 | 67,506,994.4 | 144,573,973.66 | 119,952,859.31 | 180,196,275.95 |
| 非流动负债: | | | | |
| 租赁负债 | 10,237,490.1 | 9,319,514.58 | 9,718,864.16 | 10,654,584.66 |
| 递延收益 | 31,267,583.25 | 31,743,435.48 | 32,219,287.71 | 32,657,530.77 |
| 递延所得税负债 | 24,662.25 | 33,903 | 90,327.29 | 144,194.45 |
| 非流动负债合计 | 41,529,735.6 | 41,096,853.06 | 42,028,479.16 | 43,456,309.88 |
| 负债合计 | 109,036,730 | 185,670,826.72 | 161,981,338.47 | 223,652,585.83 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 523,584,000 | 523,584,000 | 523,584,000 | 523,584,000 |
| 资本公积 | 128,194,388.22 | 128,194,388.22 | 128,194,388.22 | 128,194,388.22 |
| 其他综合收益 | 24,104.51 | 30,169.07 | 33,108.8 | 32,790.28 |
| 盈余公积 | 270,715,165.14 | 270,715,165.14 | 270,715,165.14 | 270,715,165.14 |
| 未分配利润 | 1,816,160,652.13 | 1,696,928,497.64 | 1,713,212,446.57 | 1,545,354,634.93 |
| 归属于母公司股东权益合计 | 2,738,678,310 | 2,619,452,220.07 | 2,635,739,108.73 | 2,467,880,978.57 |
| 少数股东权益 | 88,547,518.55 | 92,271,234.89 | 95,493,430.04 | 98,543,478.04 |
| 股东权益合计 | 2,827,225,828.55 | 2,711,723,454.96 | 2,731,232,538.77 | 2,566,424,456.61 |
| 负债和股东权益合计 | 2,936,262,558.55 | 2,897,394,281.68 | 2,893,213,877.24 | 2,790,077,042.44 |
| 公告日期 | 2026-04-24 | 2026-04-24 | 2025-10-24 | 2025-08-22 |
| 审计意见(境内) | | 标准无保留意见 | | |